查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1715515

脊髓刺激市場依產品類型、適應症、通路和最終用途分類－2025-2030 年全球預測

Spinal Cord Stimulation Market by Product Type, Indication, Distribution Channel, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計脊髓刺激市場在 2023 年的價值將達到 26.1 億美元，在 2024 年成長至 29.5 億美元，到 2030 年將達到 65.1 億美元，複合年成長率為 13.93%。

主要市場統計數據
基準年2023年 26.1億美元
預計2024年 29.5億美元
預測年份 2030 65.1億美元
複合年成長率（%） 13.93%

近年來，脊髓刺激已成為先進疼痛管理和神經調節療法的關鍵方面。技術創新為治療慢性和頑固性疼痛提供了廣泛的解決方案，推動了市場的穩定成長。本介紹將在此基礎上探討脊髓刺激設備的發展、其不斷擴大的臨床應用以及持續改變醫療保健格局的潛在趨勢。

脊髓刺激因其在治療複雜疼痛症候群方面的有效性而迅速引起臨床醫生和決策者的注意。隨著對微創手術和改善患者治療效果的日益重視，設備功能和營運效率的策略進步對市場發展勢頭做出了重大貢獻。了解臨床創新、技術進步和以患者為中心的設計之間的相互作用對於利用該領域的新興機會至關重要。

本報告對市場區隔、區域動態以及推動此轉變的主要企業提供了全面的見解。本介紹性概況為相關人員提供了一個簡潔而強大的框架，以了解當今影響脊髓刺激療法的多方面因素。

改變脊髓刺激市場

最近的轉型轉變重新定義了脊髓刺激市場，開創了一個以創新和不斷變化的患者期​​望為標誌的新時代。設備設計、能源效率和無線連接的進步促進了患者護理和手術結果的改善。這些技術不僅簡化了業務工作流程，也為更個人化的治療方法鋪平了道路。

在研究投入增加、監管支持以及神經調節技術更廣泛接受的推動下，市場正在經歷重大重組。隨著臨床界傾向於實證實踐，人們明顯地從傳統的疼痛管理療法轉向更有針對性的、以治療為中心的方法。將工程創新與臨床專業知識結合在一起的跨學科合作進一步推動了這一轉變。相關人員現在可以更好地利用這些進步並確保治療方案始終處於患者照護的最前沿。

此外，數位化整合的勢頭正在提供即時數據分析和改進的回饋機制，從而改變手術前和手術後的監測。這些變化強調了適應性策略對於產業參與者的重要性，並強調了持續創新對於在不斷變化的環境中保持競爭力的關鍵作用。

脊髓刺激市場的關鍵細分洞察

深入研究市場區隔可以發現一個複雜的框架，這對於理解脊髓刺激市場的多樣化動態至關重要。根據產品類型進行細分主要關注從不可充電到可充電系統的設備，每種設備在壽命、維護要求和患者相容性方面都具有獨特的優勢。技術設計的多樣性對市場採用產生了重大影響，可充電系統因其長期成本效益和便利性而越來越受到青睞。

當考慮適應症時，市場表現出根據臨床症狀分類的不同子區隔，例如複雜性局部疼痛症候群、背部手術失敗症候群和缺血性肢體疼痛。這些病理不僅決定了技術應用的特殊性，而且強調了需要客製化解決方案來有效解決特定的疼痛管理挑戰。基於適應症的方法有助於確定患者的特定需求並衡量一系列疼痛狀況的治療成功率。

此外，從銷售管道角度的洞察凸顯了線下（傳統醫療機構）和線上平台之間的差異，這些平台最近開始在設備傳播和知情患者決策中發揮關鍵作用。由於分銷管道和最終用途之間的相互作用，市場進一步細分為門診手術室、診所和醫院，每個領域都有不同的需求和業務效率。這些細分洞察的整合提供了市場力量如何相互作用和發展的清晰圖景，使行業專家能夠根據細微的市場需求量身定做他們的策略。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 腰椎手術失敗症候群和椎間盤退化性疾病（DDD）的發生率不斷上升
      • 有利的公私合營努力和新設備核准的增加
    • 限制因素
      • SCS 設備和程序高成本且替代療法可用性低
    • 機會
      • 增加對研發的投資和資金，以開發更好、更有效的SCS技術
      • 脊髓刺激裝置的技術不斷進步
    • 任務
      • 對設備故障風險和脊髓刺激治療副作用的擔憂
  • 市場區隔分析
    • 產品類型：由於設備壽命更長，可充電系統越來越受歡迎
    • 適應症：腰椎手術失敗症候群的發生率不斷上升，導致脊髓刺激治療的需求增加
    • 最終使用者：醫院中脊髓刺激裝置的使用日益增多
    • 分銷管道：日益成長的可及性和便利性正在推動消費者對線上分銷管道的偏好
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

6. 脊髓刺激市場（依產品類型）

  • 不可充電系統
  • 可充電系統

第7章脊髓刺激市場（按適應症）

  • 複雜性局部疼痛症候群
  • 背部手術失敗綜合症
  • 缺血性肢體疼痛

第 8 章脊髓刺激市場（依通路）

  • 離線
  • 線上

9. 脊髓刺激市場（依最終用途）

  • 門診手術部
  • 診所
  • 醫院

10.美洲脊髓刺激市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太脊髓刺激市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

12.歐洲、中東和非洲脊髓刺激市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023年市場佔有率分析
  • 2023年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • Abbott Laboratories
  • Axonics, Inc.
  • Beijing PINS Medical Co., Ltd
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Gimer Medical Co., Ltd.
  • Helius Medical Technologies, Inc.
  • Mainstay Medical Limited
  • Medtronic PLC
  • Nalu Medical, Inc.
  • Nevro Corp.
  • Rishena Co., Ltd.
  • Saluda Medical Pvt. Ltd.
  • Soterix Medical, Inc.
  • Teliatry, Inc.
  • WISE SpA
Product Code: MRR-0309FBC512F4

The Spinal Cord Stimulation Market was valued at USD 2.61 billion in 2023 and is projected to grow to USD 2.95 billion in 2024, with a CAGR of 13.93%, reaching USD 6.51 billion by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 2.61 billion
Estimated Year [2024] USD 2.95 billion
Forecast Year [2030] USD 6.51 billion
CAGR (%) 13.93%

In recent years, the field of spinal cord stimulation has emerged as a pivotal aspect of advanced pain management and neuromodulation therapies. The market has witnessed steady growth as technological innovations have provided a wider array of solutions to manage chronic and refractory pain conditions. This introduction lays the groundwork by exploring the evolution of spinal cord stimulation devices, the expanding clinical applications, and the underlying trends that continue to reshape the healthcare landscape.

Spinal cord stimulation has rapidly gained attention among clinical practitioners and decision-makers alike owing to its efficacy in addressing complex pain syndromes. With increasing emphasis on minimally invasive procedures and enhanced patient outcomes, strategic advancements in device functionality and operational efficiency have contributed significantly to market momentum. Understanding the interplay between clinical innovation, technological advancements, and patient-centric design is essential for capitalizing on emerging opportunities in this space.

The narrative that follows encapsulates comprehensive insights into market segmentation, regional dynamics, and influential companies driving this transformation. This introductory overview provides a concise yet robust framework for stakeholders to appreciate the multi-faceted elements influencing the spinal cord stimulation landscape today.

Transformative Shifts in the Spinal Cord Stimulation Landscape

Recent transformative shifts have redefined the spinal cord stimulation market, bringing forth a new era marked by innovation and evolving patient expectations. Advancements in device design, energy efficiency, and wireless connectivity have catalyzed improvements in both patient management and procedural outcomes. These technologies have not only streamlined operational workflows in clinical settings but have also paved the way for more personalized treatment approaches.

The market has experienced significant realignments driven by increased research investments, regulatory support, and a broader acceptance of neuromodulation techniques. As the clinical community leans towards evidence-based practices, there has been a remarkable shift from conventional pain management therapies to more targeted, therapy-centric approaches. This shift has been further accelerated by interdisciplinary collaborations that integrate engineering innovations with clinical expertise. Stakeholders are now better positioned to harness these advancements, ensuring that therapeutic solutions remain at the forefront of patient care.

Moreover, the momentum in digital integration is transforming pre-procedural and post-procedural monitoring, offering real-time data analysis and improved feedback mechanisms. These changes underscore the importance of adaptive strategies for industry players and highlight the critical role of continuous innovation in maintaining a competitive edge within this evolving landscape.

Key Segmentation Insights for Spinal Cord Stimulation Market

A deep dive into market segmentation reveals a complex framework that is crucial for understanding the diverse dynamics of the spinal cord stimulation market. The segmentation based on product type focuses on devices ranging from non-rechargeable systems to rechargeable systems, each offering unique benefits in terms of longevity, maintenance requirements, and patient adaptability. Variations in technological design have had a profound impact on market adoption, with rechargeable systems increasingly preferred for their longer-term cost effectiveness and convenience.

When examining indications, the market presents distinct sub-segments classified by clinical conditions such as complex regional pain syndrome, failed back surgery syndrome, and ischemic limb pain. These conditions not only dictate the specificity of technological applications but also emphasize the need for tailored solutions that address particular pain management challenges effectively. The indication-based approach helps in pinpointing specific patient needs and measuring therapeutic success over a diverse range of pain disorders.

Furthermore, insights from the distribution channel perspective underscore the differences between offline (traditional healthcare facilities) and online platforms that have recently started playing a critical role in device dissemination and informed patient decision-making. The interplay between distribution channels and end-use further segments the market into ambulatory surgical units, clinics, and hospitals, each of which has varying demands and operational efficiencies. Integrating these segmentation insights provides a clear picture of how market forces interact and evolve, enabling industry experts to align their strategies with nuanced market requirements.

Based on Product Type, market is studied across Non-Rechargeable Systems and Rechargeable Systems.

Based on Indication, market is studied across Complex Regional Pain Syndrome, Failed Back Surgery Syndrome, and Ischemic Limb Pain.

Based on Distribution Channel, market is studied across Offline and Online.

Based on End-Use, market is studied across Ambulatory Surgical Units, Clinics, and Hospitals.

Comprehensive Regional Dynamics in the Spinal Cord Stimulation Sector

Exploring the regional landscape, it is evident that market dynamics vary considerably across different geographies. In the Americas, the spinal cord stimulation market has benefitted from extensive clinical research and a robust healthcare infrastructure that supports rapid adoption of innovative therapies. The region's mature market base and proactive insurers further drive the uptake of advanced neuromodulatory solutions.

In Europe, the Middle East and Africa, growing awareness and evolving regulatory pathways continue to foster significant investments in research and development. This unique blend of stringent regulatory standards with emerging market conditions is shaping a competitive environment that challenges established treatment paradigms while fostering localized innovations. The emphasis on quality, safety, and cost-effectiveness in these regions has led to a broader acceptance of spinal cord stimulation technologies in both urban and rural clinical settings.

Asia-Pacific, with its dynamic growth and rapidly expanding healthcare sector, stands out as one of the most promising regions for spinal cord stimulation. The convergence of increasing patient awareness, heightened focus on non-invasive therapies, and supportive government initiatives has catalyzed market growth. These regional insights highlight considerable heterogeneity in market maturity, patient demographics, and regulatory frameworks that collectively influence the deployment and effectiveness of spinal cord stimulation therapies across the globe.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Major Industry Players and Market Leaders in Spinal Cord Stimulation

The landscape of spinal cord stimulation is characterized by robust competition among leading industry players, each of whom contributes to the market's evolution through technological innovation and strategic partnerships. Over the years, companies such as Abbott Laboratories and Axonics, Inc. have established themselves as pioneers with a strong focus on clinical efficacy and sustainability. Their commitment to advancing neuromodulation solutions has set benchmarks for the industry.

Other significant players like Beijing PINS Medical Co., Ltd and BIOTRONIK SE & Co. KG bring a combination of engineering excellence and clinical expertise to the market, while Boston Scientific Corporation and Gimer Medical Co., Ltd. continue to widen the scope of pain management through transformative device portfolios. Helius Medical Technologies, Inc., Mainstay Medical Limited, and Medtronic PLC further underscore the intense competitive landscape by investing in next-generation technologies that enhance patient experiences and improve long-term clinical outcomes.

Emerging innovators such as Nalu Medical, Inc. and Nevro Corp. play a pivotal role in driving technological disruption, complemented by the strategic initiatives of Rishena Co., Ltd., Saluda Medical Pvt. Ltd., and Soterix Medical, Inc. Their collaborative efforts, research breakthroughs, and sustained market presence indicate a robust commitment to reimagining therapeutic paradigms. In addition, Teliatry, Inc. and WISE SpA have contributed to a diversified and resilient portfolio of solutions that respond effectively to the evolving clinical demands of spinal cord stimulation. Together, these companies shape a competitive environment that continues to push the envelope of technological advancement and best-in-class patient care.

The report delves into recent significant developments in the Spinal Cord Stimulation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Axonics, Inc., Beijing PINS Medical Co., Ltd, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Gimer Medical Co., Ltd., Helius Medical Technologies, Inc., Mainstay Medical Limited, Medtronic PLC, Nalu Medical, Inc., Nevro Corp., Rishena Co., Ltd., Saluda Medical Pvt. Ltd., Soterix Medical, Inc., Teliatry, Inc., and WISE SpA. Strategic Actionable Recommendations for Industry Leaders

For industry leaders seeking to capitalize on new opportunities in the spinal cord stimulation market, a strategic, multifaceted approach is essential. Emphasizing research and development is paramount, with a focus on integrating advanced digitalization efforts and hybrid models of device management. Leaders should prioritize investment in technologies that enhance device functionality, robustness, and patient usability, while also ensuring rigorous compliance with evolving regulatory standards.

It is imperative to expand market penetration by establishing strong alliances with healthcare providers and clinical research organizations. Developing differentiated product portfolios tailored to specific pain indications can drive competitive advantages. Decision-makers are encouraged to leverage data analytics to monitor efficacy and optimize patient outcomes, thereby reinforcing long-term trust and credibility with stakeholders.

Furthermore, an adaptive marketing strategy that resonates with both traditional healthcare professionals and digitally engaged consumers will be key. Diversification of distribution channels, including enhanced online platforms alongside established offline networks, can broaden market reach. By nurturing innovation, optimizing operational efficiency, and maintaining agility in response to emerging trends, industry leaders can effectively shape the future trajectory of spinal cord stimulation.

Conclusion and Forward Outlook for Spinal Cord Stimulation

The evolving landscape of spinal cord stimulation presents both challenges and opportunities that call for a strategic, well-informed approach. Over the course of this analysis, it is evident that technological advancements, evolving patient expectations, and robust market segmentation play crucial roles in defining current trends and future trajectories. From transformative shifts in device technology to the nuanced demands of varied geographic regions, the industry stands at a critical juncture where innovation meets clinical necessity.

A comprehensive understanding of market dynamics is imperative for stakeholders who seek sustainable growth. The detailed exploration of segmentation insights and regional dynamics, alongside an evaluation of the competitive player landscape, underscores the importance of adaptability and continuous advancement. With a clear focus on targeted interventions and cutting-edge research, the spinal cord stimulation market is poised to deliver enhanced patient outcomes while driving financial performance.

As the industry continues to evolve, it is crucial for decision-makers to remain adaptive, anticipating emerging trends and aligning strategic initiatives with the latest technological breakthroughs. This forward outlook serves as a clarion call for innovation and excellence in clinical care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of failed back surgery syndrome and degenerative disk disease (DDD)
      • 5.1.1.2. Favorable public-private initiatives and increasing approvals for new device
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of SCS devices and procedures and availability of alternative therapies
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment and funding in research and development for better and more effective SCS technologies
      • 5.1.3.2. Ongoing technological advancements in spinal cord stimulation devices
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of device malfunction and concerns associated with adverse effects of spinal cord stimulation
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Growing preference for rechargeable systems owing to longer device lifespan
    • 5.2.2. Indication: Rising need for spinal cord stimulation with the growing incidences of failed back surgery syndrome
    • 5.2.3. End-user: Growing utilization of spinal cord stimulation devices in hospitals
    • 5.2.4. Distribution Channel: Increasing consumer preference for online distribution channels owing to greater accessibility and convenience
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Spinal Cord Stimulation Market, by Product Type

  • 6.1. Introduction
  • 6.2. Non-Rechargeable Systems
  • 6.3. Rechargeable Systems

7. Spinal Cord Stimulation Market, by Indication

  • 7.1. Introduction
  • 7.2. Complex Regional Pain Syndrome
  • 7.3. Failed Back Surgery Syndrome
  • 7.4. Ischemic Limb Pain

8. Spinal Cord Stimulation Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Offline
  • 8.3. Online

9. Spinal Cord Stimulation Market, by End-Use

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Units
  • 9.3. Clinics
  • 9.4. Hospitals

10. Americas Spinal Cord Stimulation Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Spinal Cord Stimulation Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Spinal Cord Stimulation Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Wise secures funding to boost development of HERON Lead in spinal cord stimulation
    • 13.3.2. Medtronic recieves FDA approval for Inceptiv closed-loop spinal cord stimulator
    • 13.3.3. FDA approves Boston Scientific's spinal cord stimulator systems for non-surgical back pain relief
    • 13.3.4. The University of Alabama at Birmingham's innovative spinal cord stimulator therapy enhances chronic pain management with real-time adjustments
    • 13.3.5. Abbott recieves FDA Approval for expanded use of spinal cord stimulation systems
    • 13.3.6. Saluda Medical secures USD 150 million funding to transform chronic pain treatment with Evoke system
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. Boston Scientific Corporation
    • 13.4.2. Medtronic PLC
    • 13.4.3. Abbott Laboratories
    • 13.4.4. Nevro Corp.

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Axonics, Inc.
  • 3. Beijing PINS Medical Co., Ltd
  • 4. BIOTRONIK SE & Co. KG
  • 5. Boston Scientific Corporation
  • 6. Gimer Medical Co., Ltd.
  • 7. Helius Medical Technologies, Inc.
  • 8. Mainstay Medical Limited
  • 9. Medtronic PLC
  • 10. Nalu Medical, Inc.
  • 11. Nevro Corp.
  • 12. Rishena Co., Ltd.
  • 13. Saluda Medical Pvt. Ltd.
  • 14. Soterix Medical, Inc.
  • 15. Teliatry, Inc.
  • 16. WISE SpA

LIST OF FIGURES

  • FIGURE 1. SPINAL CORD STIMULATION MARKET MULTI-CURRENCY
  • FIGURE 2. SPINAL CORD STIMULATION MARKET MULTI-LANGUAGE
  • FIGURE 3. SPINAL CORD STIMULATION MARKET RESEARCH PROCESS
  • FIGURE 4. SPINAL CORD STIMULATION MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. SPINAL CORD STIMULATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. SPINAL CORD STIMULATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SPINAL CORD STIMULATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SPINAL CORD STIMULATION MARKET DYNAMICS
  • TABLE 7. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY NON-RECHARGEABLE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY RECHARGEABLE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY COMPLEX REGIONAL PAIN SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY FAILED BACK SURGERY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY ISCHEMIC LIMB PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY AMBULATORY SURGICAL UNITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. SPINAL CORD STIMULATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. SPINAL CORD STIMULATION MARKET, FPNV POSITIONING MATRIX, 2023